HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

placental ribonuclease inhibitor

RNasin, is a purified human placental ribonuclease inhibitor, known to have antiangiogenic activity through the inhibition of angiogenin and basic fibroblast growth factor
Also Known As:
RNasin, placental RNase inhibitor; nuclease inhibitor, RNasin; placental RNase inhibitor; ribonuclease inhibitor (placental); ribonuclease-angiogenin inhibitor
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Rucksaken, Rucksak: 1 article (01/2014)
2. Roytrakul, Sittiruk: 1 article (01/2014)
3. Pairojkul, Chawalit: 1 article (01/2014)
4. Pinlaor, Porntip: 1 article (01/2014)
5. Khuntikeo, Narong: 1 article (01/2014)
6. Selmi, Carlo: 1 article (01/2014)
7. Pinlaor, Somchai: 1 article (01/2014)
8. Wang, Szu-Chi: 1 article (01/2011)
9. Balraj, Gopula: 1 article (01/2011)
10. Tang, Yen-An: 1 article (01/2011)

Related Diseases

1. Cholangiocarcinoma
2. Teratoma (Teratoid Tumor)
3. Neoplasms (Cancer)
4. Neoplasm Metastasis (Metastasis)
5. Hydatidiform Mole (Molar Pregnancy)

Related Drugs and Biologics

1. HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
2. Complementary DNA (cDNA)
3. Biological Markers (Surrogate Marker)
4. Vimentin
5. Messenger RNA (mRNA)
6. RNA (Ribonucleic Acid)
7. Proteins (Proteins, Gene)
8. Phosphopyruvate Hydratase (Enolase)
9. Cathepsin D
10. Autoantibodies